(Q37404837)

20 August 2017

1 reference

title

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities (English)

1 reference

20 August 2017

0 references

1 reference

Rodolfo Viotti

1

1 reference

20 August 2017

Carlos Vigliano

2

1 reference

20 August 2017

Bruno Lococo

3

1 reference

20 August 2017

Maria Gabriela Alvarez

4

1 reference

20 August 2017

Marcos Petti

5

1 reference

20 August 2017

Graciela Bertocchi

6

1 reference

20 August 2017

Alejandro Armenti

7

1 reference

20 August 2017

language of work or name

1 reference

1 March 2009

1 reference

Expert Review of Anti-infective Therapy

20 August 2017

published in

1 reference

20 August 2017

volume

7

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

157-163

1 reference

on focus list of Wikimedia project

20 August 2017

ScienceSource

0 references

cites work

A 9,000-year record of Chagas' disease

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Chagas' heart disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Diagnóstico, manejo y tratamiento de la cardiopatía chagásica crónica en áreas donde la infección por Trypanosoma cruzi no es endémica

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Chagas disease and the US blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Longitudinal study and specific chemotherapy in children with chronic Chagas' disease, residing in a low endemicity area of Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Where do we stand on the autoimmunity hypothesis of Chagas disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Pathophysiology of the heart in Chagas' disease: current status and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Etiological treatment of chronic Chagas disease: neglected 'evidence' by evidence-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Pathogenesis of chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Parasite persistence in the aetiology of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Evaluation and treatment of chagas disease in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

Clinical predictors of chronic chagasic myocarditis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.2.157

21 January 2018

Identifiers

DOI

10.1586/14787210.7.2.157

1 reference

20 August 2017

1 reference